![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Andersson K., Ryde-Blomqvist E., Lindell K., Odlind V. and Milsom I. (1998) Perforation and intrauterine devices. Report from a Swedish survey. Contraception, 57, 251 —255.
- Haimov-Kochman R., Amsalem H., Adoni A., Lavy Y. and Spitz I. (2003) Management of a perforated levonogestrel-medicated intrau-terine device—a pharmacokinetic study. Human Reproduction, 18, 1231–1233.
- Haimov-Kochman R., Doviner V., Amsalem H., Prus D., Adoni A. and Lavy Y. (2003) Intraperitoneal levonorgestrel-releasing intrau-terine device following uterine perforation: the role of progestins in adhesion formation. Human Reproduction, 18, 990–993.
- Phupong V., Sueblinvog T., Pruksananonda K., Taneepanichskul S. and Triratanachat S. (2000) Uterine perforation with Lippes loop intrauterine device-associated actinomycosis: a case report and review of the literature. Contraception, 61, 347–350.
- Selo-Ojeme D., Ekong M. and Welsh C. (2003) Uterine perforation and laparoscopic retrieval of a levonogestrel intrauterine system. Journal of Obstetrics and Gynaecology, 23, 445–446.
- Serryan R.F.M. (1989) Endoscopic removal of intrauterine contra-ceptive devices. In: State of the Art IUD, edited by van der Pas H.F.M. and Dieben TOM., 1st edn, pp.173— 177. London, Kluwer Academic Publishers.
- World Health Organisation/International Planned Parenthood Foun-dation (2003) IMAP statement on intrauterine devices. IPPF Medical Bulletin, 37, 1–5.